Clinical Trial Update: Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanubrutinib [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial examines clonal dynamics in chronic lymphocytic leukemia patients treated with pirtobrutinib after prior zanubrutinib treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Pirtobrutinib (pirtobrutinib)
• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: RECRUITING